Skip to main content
VTRS
NASDAQ Life Sciences

Viatris Sells Tyrvaya for Up to $100M, Lifts 2026 Guidance

Tom Rudovsky · Reported by Benzinga
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$17.1
Mkt Cap
$20.07B
52W Low
$8.735
52W High
$18.39
52W Position info
96% above low
Off High info
7.0% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

VTRS sits 96% above its 52-week low of $8.735.

Summary

Viatris is selling its dry-eye drug Tyrvaya to Harrow for up to $100 million — $30 million cash upfront plus $70 million in sales milestones. The deal sharpens the company's focus on complex generics and transdermal products. Alongside the divestiture, Viatris raised its full-year 2026 adjusted EPS guidance to $2.45–$2.49 (from $2.33–$2.47) and revenue to $14.55B–$14.95B (from $14.45B–$14.95B), both above consensus. This follows this morning's Q2 beat of $3.76B revenue and $0.69 EPS, reinforcing the turnaround narrative. The stock fell 4% on the day, likely reflecting profit-taking after the strong quarter.

At the time of this announcement, VTRS was trading at $17.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.1B. The 52-week trading range was $8.74 to $18.39. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

VTRS - Latest Insights

VTRS
Nov 12, 2026, 4:16 PM EST
Filing Type: SC TO-T/A
Importance Score:
7
Price at Filing: $20.69
Real-time Price: $20.90 info
Change: +$0.2104 (+1%) info
Market Cap: $23.869B info
VTRS
Nov 05, 2026, 9:23 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.40
Real-time Price: $20.90 info
Change: +$1.50 (+8%) info
Market Cap: $23.869B info
VTRS
Nov 05, 2026, 7:45 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.33
Real-time Price: $20.90 info
Change: +$1.57 (+8%) info
Market Cap: $23.869B info
VTRS
Nov 05, 2026, 6:59 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $19.36
Real-time Price: $20.90 info
Change: +$1.54 (+8%) info
Market Cap: $23.869B info
VTRS
Oct 30, 2026, 7:40 AM EDT
Filing Type: SC TO-T
Importance Score:
8
Price at Filing: $19.30
Real-time Price: $20.90 info
Change: +$1.60 (+8%) info
Market Cap: $23.869B info